164 results
Page 3 of 9
8-K
EX-99.1
m23jx4poy
5 Aug 14
Discovery Labs Reports Second Quarter 2014 Financial Results
12:00am
424B5
qkawhvg2rl4878o
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
mmfyydw
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
sveqt1cz9 p7
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
mpmm68ybs n480nv83t
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
424B5
gvknf
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
0hniz
13 Mar 13
Discovery Labs Reports Fourth Quarter 2012 Financial Results
12:00am
424B5
gh7804k
13 Feb 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
r0vpeldvtg3w qiur1
4 Jan 13
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
12:00am